Clinical Ophthalmology (Aug 2023)
Surgical Augmentation of the Suprachoroidal Space: A Novel Material and Implant
Abstract
Ticiana De Francesco,1– 3 Iqbal Ike K Ahmed3,4 1Clinica de Olhos De Francesco, Fortaleza, Brazil; 2Hospital de Olhos Leiria de Andrade (HOLA), Fortaleza, Brazil; 3John A. Moran Eye Center, University of Utah, Salt Lake City, UT, USA; 4Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, ON, CanadaCorrespondence: Ticiana De Francesco, 499 Barao de Aracati, Fortaleza, Brazil, Tel +55 85 3219-24-25, Email [email protected]: Microinvasive glaucoma surgery (MIGS) has emerged as a safer method to lower IOP with minimal impact on patient quality of life compared to traditional glaucoma surgeries. With the advent of MIGS, there has been a renewed interest in exploring the suprachoroidal route. MIGS targeting the suprachoroidal space allow for a safe reduction in IOP while sparing conjunctiva and allowing “blebless” surgery, thus avoiding bleb-related complications. This article aims to review the rationale behind the suprachoroidal MIGS procedures and the literature surrounding the efficacy and safety of a novel suprachoroidal device, the MINIject. The available literature has shown promising IOP lowering results with the MINIject implant with a potentially safer and less invasive approach than traditional glaucoma surgeries.Keywords: suprachoroidal space, microinvasive glaucoma surgery, glaucoma
